Interpace Biosciences, Inc. Stock
Stocks
IDXG.D
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
OTC Markets
23:53:58 28/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.618 USD | +5.08% |
|
+0.05% | +23.85% |
| Market Cap | 42.21M 36.37M 34.1M 31.13M 58.64M 4.03B 58.83M 405M 158M 2.04B 158M 155M 6.75B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 40.88M 35.23M 33.03M 30.15M 56.8M 3.91B 56.98M 392M 153M 1.97B 153M 150M 6.54B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.08% | ||
| 1 week | +0.05% | ||
| Current month | +0.44% | ||
| 1 month | -1.86% | ||
| 3 months | -15.36% | ||
| 6 months | -14.60% | ||
| Current year | +23.85% |
| 1 week | 6.5 |  | 7.85 |
| 1 month | 6.5 | | 8.5 |
| Current year | 5.15 | | 12 |
| 1 year | 3.85 | | 12 |
| 3 years | 2.22 | | 17.7 |
| 5 years | 2.22 | | 51.65 |
| 10 years | 2.22 | | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/08/26 | Free | Director | 69,252 | 0.2501% | ||
| 20/08/26 | Fiscal year | Chief Financial Officer | 1,385,045 | 5.0015% | ||
| 20/08/26 | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.08% | +0.05% | +84.68% | +49.37% | 42.21M | |
| -3.67% | -1.74% | +94.34% | +487.75% | 47.03B | |
| -0.21% | -0.37% | +21.73% | +57.89% | 27.18B | |
| -0.30% | -4.93% | -16.15% | -37.78% | 7.1B | |
| -1.00% | -2.88% | +3.93% | +134.99% | 5.87B | |
| -0.27% | +1.95% | +16.22% | +76.62% | 3.38B | |
| -3.26% | -0.84% | -33.07% | +1,921.90% | 2.57B | |
| -3.17% | +6.30% | +150.35% | +30.70% | 2.32B | |
| +1.02% | +1.02% | +29.25% | +25.80% | 1.97B | |
| -1.93% | -12.54% | -14.69% | -54.48% | 1.89B | |
| Average | -0.77% | -0.92% | +33.66% | +269.28% | 9.94B | |
| Weighted average by Cap. | -2.06% | -1.38% | +53.22% | +304.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.44M 37.91M 34.61M 65.2M 4.48B 65.41M 450M 175M 2.26B 176M 172M 7.51B | 38.73M 33.37M 31.29M 28.56M 53.81M 3.7B 53.98M 371M 145M 1.87B 145M 142M 6.2B |
| Net income | 6.7M 5.78M 5.41M 4.94M 9.31M 641M 9.34M 64.24M 25.06M 323M 25.16M 24.62M 1.07B | 24.58M 21.18M 19.85M 18.12M 34.14M 2.35B 34.25M 236M 91.91M 1.19B 92.27M 90.26M 3.93B |
| Net Debt | 4.4M 3.79M 3.55M 3.24M 6.11M 420M 6.13M 42.13M 16.44M 212M 16.5M 16.14M 703M | -1.32M -1.14M -1.07M -975K -1.84M -126M -1.84M -12.67M -4.94M -63.78M -4.96M -4.86M -211M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | $7.618 | +5.08% | 2,520 |
| 26/08/26 | $7.250 | +2.11% | 1,420 |
| 25/08/26 | $7.100 | -0.70% | 1,299 |
| 24/08/26 | $7.150 | -6.09% | 402 |
| 21/08/26 | $7.614 | -5.42% | 1,965 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG.D Stock
Select your edition
All financial news and data tailored to specific country editions
